New non competitive AMPA antagonists.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Bioorganic & Medicinal Chemistry

• Publication date

  2000-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0968-0896(00)00133-4PMID 11003158
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• GYKI 52466 , a 2 , 3 = Benzodiazepine , Is a Highly Selective , Noncompetitive Antagonist of AMPA / Kainate Receptor Responses

  2003cited by this paper
• Anxiolytic 2,3-benzodiazepines, their specific binding to the basal ganglia.

  2000cited by this paper
• Synthesis and anticonvulsant activity of 3-aryl-5H-2,3-benzodiazepine ampa antagonists

  1999cited by this paper
• Synthesis and anticonvulsant activity of novel and potent 2,3-benzodiazepine AMPA/kainate receptor antagonists.

  1999cited by this paper
• Synthesis and anticonvulsant activity of 3-aryl-5H-2,3-benzodiazephine AMPA antagonists.

  1999cited by this paper
• Synthesis of 7,8-(methylenedioxy)-1-phenyl-3,5-dihydro-4H-2, 3-benzodiazepin-4-ones as novel and potent noncompetitive AMPA receptor antagonists.

  1998cited by this paper
• 7,8-Methylenedioxy-4H-2,3-benzodiazepin-4-ones as novel AMPA receptor antagonists.

  1998cited by this paper
• Glutamate in CNS disorders as a target for drug development: an update.

  1998cited by this paper
• Glutamate Antagonists for Parkinson’s Disease

  1998cited by this paper
• 3,5-Dihydro-4H-2,3-benzodiazepine-4-thiones: a new class of AMPA receptor antagonists.

  1998cited by this paper
• 2,3-Benzodiazepine AMPA Antagonists

  1998cited by this paper
• 1-Aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: novel AMPA receptor antagonists.

  1997cited by this paper
• Activity of 2,3-benzodiazepines at native rat and recombinant human glutamate receptors in vitro: stereospecificity and selectivity profiles.

  1996cited by this paper
• The effect of chlormethiazole on neuronal damage in a model of transient focal ischaemia

  1995cited by this paper
• Synthesis and reactivity of pyrrolo[1,2‐α]quinoxalines. Crystal structure and AM1 calculation

  1995cited by this paper
• Application of a Practical Biocatalytic Reduction to an Enantioselective Synthesis of the 5H-2,3-Benzodiazepine LY300164

  1995cited by this paper
• Triggering and execution of neuronal death in brain ischaemia: two phases of glutamate release by different mechanisms.

  1994cited by this paper
• Glutamatergic drugs in Parkinson's disease.

  1994cited by this paper
• Amino acids as dietary excitotoxins: a contribution to understanding neurodegenerative disorders.

  1993cited by this paper
• The triggering of spreading depression in the chicken retina: a pharmacological study.

  1993cited by this paper
• Structure-activity relationships of 2,3-benzodiazepine compounds with glutamate antagonistic action

  1993cited by this paper
• Cerebroprotective Effect of a Non–N‐Methyl‐D‐Aspartate Antagonist, GYKI 52466, After Focal Ischemia in the Rat

  1992cited by this paper
• The non-NMDA antagonists, NBQX and GYKI 52466, protect against cortical and striatal cell loss following transient global ischaemia in the rat.

  1992cited by this paper
• The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in mice.

  1991cited by this paper
• The non-N-methyl-D-aspartate receptor antagonists, GYKI 52466 and NBQX are anticonvulsant in two animal models of reflex epilepsy.

  1991cited by this paper
• SYNTHESIS OF a-AMINOALDEHYDES AND a-AMINOKETONES. A REVIEW

  1990cited by this paper
• Functional architecture of basal ganglia circuits: neural substrates of parallel processing.

  1990cited by this paper
• Electrophysiological studies with a 2,3-benzodiazepine muscle relaxant: GYKI 52466.

  1989cited by this paper
• Reversible middle cerebral artery occlusion without craniectomy in rats.

  1989cited by this paper
• Perfluorinated acids as ion-pairing agents in the determination of monoamine transmitters and some prominent metabolites in rat brain by high-performance liquid chromatography with amperometric detection.

  1988cited by this paper
• Pharmacology of a new centrally acting muscle relaxant

  1988cited by this paper
• Abstract of papers

  1987cited by this paper
• Stereoselective synthesis of (2s,3s,4r)-4-amino-3-hydroxy-2-methyl-pentanoic acid, an amino acid constituent of bleomycin, by aldold condensation)☆

  1982cited by this paper
• The Use of Diethyl Azodicarboxylate and Triphenylphosphine in Synthesis and Transformation of Natural Products

  1981cited by this paper
• Inhibitors of neuronal monoamine uptake. 2. Selective inhibition of 5-hydroxytryptamine uptake by alpha-amino acid esters of phenethyl alcohols.

  1978cited by this paper
• Reductive deamination of arylamines by alkyl nitrites in N,N-dimethylformamide. A direct conversion of arylamines to aromatic hydrocarbons

  1977cited by this paper
• Recherches en série azabenzodiazepine V. Synthése de bis s-triazolo[4,3-b:4,3-d] triaze'pines-1,2,4

  1976cited by this paper
• Pyrazines. I. Syntheses of 2,3-dihydroxypyrazines and their derivatives

  1972cited by this paper
• Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse

  1968cited by this paper
• CHAPTER 5 - QUANTAL RESPONSES. CALCULATION OF THE ED 50

  1965cited by this paper
• Screening methods in pharmacology

  1965cited by this paper
• Hydrazine as a Reducing Agent for Organic Compounds (Catalytic Hydrazine Reductions)

  1965cited by this paper
• Amitriptyline and nortriptyline as antagonists of central and peripheral cholinergic activation

  1963cited by this paper
• The psychosedative properties of methaminodiazepoxide.

  1960cited by this paper
• Electronic Effects in Elimination Reactions. II. The E2 Reaction1a,b

  1957cited by this paper
• A note on a simple apparatus for detecting neurological deficit in rats and mice.

  1957cited by this paper
• Electronic Effects in the Lithium Borohydride Reduction of Styrene Oxides1

  1956cited by this paper
• Comparison of maximal seizures evoked by pentylenetetrazol (metrazol) and electroshock in mice, and their modification by anticonvulsants.

  1953cited by this paper
• Comparative assays of antiepileptic drugs in mice and rats.

  1952cited by this paper
• A simplified method of evaluating dose-effect experiments.

  1948cited by this paper

• Do AMPA/kainate antagonists possess potential in the treatment of addiction? Evidence from animal behavioural studies.

  2025cites this paper
• Full Oxidation of an α-Arylated Isochromane: Development of a Two-Step Sequence as an Alternative to the Carcinogenic Jones Reagent and Application to the Manufacturing Process of Servier Phase II Clinical Candidate S44819

  2025cites this paper
• Boosting Molecular Complexity with O2 : Iron-Catalysed Oxygenation of 1-Arylisochromans through Dehydrogenation, Csp3 -O Bond Cleavage and Hydrogenolysis.

  2019cites this paper
• Catalyst‐Free Synthesis of 2,3‐Benzodiazepines via Tetrahydrodiazirino[3,1‐a]isoquinoline Reacts with Sulfonyl Chlorides

  2019cites this paper
• Synthesis of new tricyclic imidazotriazepine derivatives condensed with various heterocycles

  2017cites this paper
• Pictet–Spengler reaction in the synthesis of condensed benzodiazepines: synthesis of 11-hetaryl derivatives of 11,12-dihydroquinazolino[3,2-c][2,3]benzodiazepin-14(6H)-ones

  2017cites this paper
• Oxidative cleavage of 1-aryl-isochroman derivatives using the Trametes villosa laccase/1-hydroxybenzotriazole system

  2016cites this paper
• Novel tetracyclic benzo[b]carbazolones as highly potent and orally bioavailable ALK inhibitors: design, synthesis, and structure-activity relationship study.

  2015cites this paper
• A novel GABA(A) alpha 5 receptor inhibitor with therapeutic potential.

  2015cites this paper
• Structure activity relationships of novel antiepileptic drugs.

  2014cites this paper
• Mechanism and site of inhibition of AMPA receptors: pairing a thiadiazole with a 2,3-benzodiazepine scaffold.

  2014cites this paper
• Perampanel Inhibition of AMPA Receptor Currents in Cultured Hippocampal Neurons

  2014cites this paper
• Synthesis of Dihydrothienopyridine Derivatives Fused with Triazole Rings

  2013cites this paper
• The Pharmacology of l-DOPA-Induced Dyskinesia in Parkinson’s Disease

  2013cites this paper
• Studies on an (S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA) receptor antagonist IKM-159: asymmetric synthesis, neuroactivity, and structural characterization.

  2013cites this paper
• AMPA receptors as a molecular target in epilepsy therapy

  2013cites this paper
• Temporal alteration of spreading depression by the glycine transporter type-1 inhibitors NFPS and Org-24461 in chicken retina.

  2013cites this paper
• Aptamers Targeting a Subunit or a Conformation of Glutamate Ion Channel Receptors

  2013cites this paper
• Synthesis and Evaluation of Anticonvulsant Activity of 6,8-Dimethoxy-3-methyl-1,2,3,4-tetrahydroisoquinoline in PTZ-Induced Seizure Model in Mice

  2012cites this paper
• Glutamatergic neurotransmission as molecular target of new anticonvulsants.

  2012cites this paper
• New AMPA antagonists in epilepsy

  2012cites this paper
• Glutamate Excitotoxicity Is Involved in the Induction of Paralysis in Mice after Infection by a Human Coronavirus with a Single Point Mutation in Its Spike Protein

  2011cites this paper
• Biological importance of imidazole nucleus in the new millennium

  2011cites this paper
• AMPA receptor synaptic plasticity induced by psychostimulants: the past, present, and therapeutic future.

  2010cites this paper
• alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonists: from bench to bedside.

  2010cites this paper
• Inhibition of Calcineurin-mediated Endocytosis and α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors Prevents Amyloid β Oligomer-induced Synaptic Disruption

  2009cites this paper
• Combined Strategies for the Discovery of Ionotropic Glutamate Receptor Antagonists

  2009cites this paper
• Antagonists of AMPA/KA and NMDA (glycine site) glutamate receptors

  2008cites this paper
• 2,3-benzodiazepine-type AMPA receptor antagonists and their neuroprotective effects.

  2008cites this paper
• Enhancement of anti-absence effects of ethosuximide by low doses of a noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist in a genetic animal model of absence epilepsy.

  2008cites this paper
• The new 2,3-benzodiazepine derivative EGIS-8332 inhibits AMPA/kainate ion channels and cell death.

  2007cites this paper
• Effects of 2,3-benzodiazepine AMPA receptor antagonists on dopamine turnover in the striatum of rats with experimental parkinsonism.

  2007cites this paper
• New strategy for the synthesis of tetrahydrobenzothieno-[1,2]diazepines

  2007cites this paper
• Neuroprotective and anticonvulsant effects of EGIS‐8332, a non‐competitive AMPA receptor antagonist, in a range of animal models

  2007cites this paper
• Therapeutic time window of neuroprotection by non-competitive AMPA antagonists in transient and permanent focal cerebral ischemia in rats.

  2006cites this paper
• Talampanel improves the functional deficit after transient focal cerebral ischemia in rats. A 30-day follow up study.

  2006cites this paper
• Generation of spike wave discharges in absence epilepsy : Modulatory effects of serotonin , glutamate and glycine

  2006cites this paper
• Cell cycle-dependent regulation of kainate-induced inward currents in microglia.

  2006cites this paper
• Influence of the N-acetylation polymorphism on the metabolism of talampanel: an investigation in fasted and fed subjects genotyped for NAT2 variants.

  2006cites this paper
• The AMPA-antagonist talampanel is neuroprotective in rodent models of focal cerebral ischemia.

  2005cites this paper
• Potential metabolites of a condensed 2,3-benzodiazepine derivative.

  2005cites this paper
• Ionotropic and metabotropic glutamate receptor structure and pharmacology

  2005cites this paper
• Pharmacological characterization of stress-induced hyperthermia in DBA/2 mice using metabotropic and ionotropic glutamate receptor ligands

  2005influential citation
• AMPA receptor antagonists as potential anticonvulsant drugs.

  2005cites this paper
• Emerging therapies in multiple sclerosis

  2005cites this paper
• Procedes et compositions pour traiter les troubles inflammatoires des voies aeriennes

  2004cites this paper
• Comparison of the AMPA Antagonist Action of New 2,3-Benzodiazepines in Vitro and Their Neuroprotective Effects in Vivo

  2004cites this paper
• Effect of two noncompetitive AMPA receptor antagonists GYKI 52466 and GYKI 53405 on vigilance, behavior and spike-wave discharges in a genetic rat model of absence epilepsy.

  2004cites this paper
• Reduction of cerebral infarct size by non-competitive AMPA antagonists in rats subjected to permanent and transient focal ischemia.

  2004cites this paper
• Interactions of allosteric modulators of AMPA/kainate receptors on spreading depression in the chicken retina.

  2004cites this paper
• Heterogeneity and potentiation of AMPA type of glutamate receptors in rat cultured microglia

  2004cites this paper
• Neurotransmitter release in experimental stroke models: the role of glutamate-GABA interaction.

  2004cites this paper
• Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII).

  2004cites this paper
• Pharmacology and prospective therapeutic usefulness of negative allosteric modulators of AMPA receptors

  2004cites this paper
• New trends in the development of AMPA receptor antagonists

  2004cites this paper
• Synthesis of Tetrahydropyridoimidazole‐2‐acetates: Effect of Carboxy and Methoxycarbonyl Groups at C(2) on the Inhibition of Some β‐ and α‐Glycosidases

  2004cites this paper
• Synthesis of new 1,2‐dihydrophthalazines

  2002cites this paper
• Pharmacology of Glutamate Receptors

  2002cites this paper
• Protective effect of the antiepileptic drug candidate talampanel against AMPA-induced striatal neurotoxicity in neonatal rats.

  2002cites this paper
• Non-competitive AMPA antagonists of 2,3-benzodiazepine type.

  2002cites this paper
• The role of ionotropic glutamate receptors in nociception with special regard to the AMPA binding sites.

  2002cites this paper
• Excitatory amino acids.

  2002cites this paper
• Research on new AMPA antagonists of 2,3-benzodiazepine type.

  2001cites this paper
• Thin-Layer Chromatographic Characterization of Metabolites Formed from an AMPA Antagonist Drug Candidate

  2001cites this paper
• Synthesis and structure-activity relationships of 2,3-benzodiazepines as AMPA receptor antagonists.

  2001cites this paper